E-LIB Suche - Ergebnisse für: Al‐Huniti, N.H.

1

Pharmacokinetic tracer kinetics analysis of changes in eryt..:

Veng‐Pedersen, P. ; Chapel, S. ; Al‐Huniti, N.H....
Biopharmaceutics & Drug Disposition. 25 (2004) 4 - p. 149-156 , 2004

Link: https://doi.org/10.1002/..

2

Erythropoietin production rate in phlebotomy‐induced acute ..:

Al‐Huniti, N.H. ; Widness, J.A. ; Schmidt, R.L..
Biopharmaceutics & Drug Disposition. 25 (2004) 9 - p. 389-397 , 2004

Link: https://doi.org/10.1002/..

3

Change in Erythropoietin Pharmacokinetics Following Hematop..:

Widness, J A ; Schmidt, R L ; Hohl, R J...
Clinical Pharmacology & Therapeutics. 81 (2007) 6 - p. 873-879 , 2007

Link: https://doi.org/10.1038/..

4

Individualized pharmacokinetic risk assessment for developm..:

Gupta, N. ; Al-Huniti, N.H. ; Veng-Pedersen, P.
Diabetes Research and Clinical Practice. 78 (2007) 1 - p. 93-101 , 2007

Link: https://doi.org/10.1016/..

5

Pharmacometric Modeling of Naloxegol Efficacy and Safety: I..:

Al‐Huniti, N ; Zhou, D ; Xu, H...
Clinical Pharmacology & Therapeutics. 102 (2017) 5 - p. 741-744 , 2017

Link: https://doi.org/10.1002/..

6

Model Evaluation of Continuous Data Pharmacometric Models: ..:

Nguyen, T. H. T. ; Mouksassi, M‐S ; Holford, N...
CPT: Pharmacometrics & Systems Pharmacology. 6 (2017) 2 - p. 87-109 , 2017

Link: https://doi.org/10.1002/..

7

Predictive Performance of Physiologically Based Pharmacokin..:

Zhou, W ; Johnson, TN ; Xu, H...
CPT: Pharmacometrics & Systems Pharmacology. 5 (2016) 9 - p. 475-483 , 2016

Link: https://doi.org/10.1002/..

8

Population pharmacokinetic modelling to assess clinical dru..:

Zhou, D. ; Lu, Z. ; Sunzel, M...
Journal of Clinical Pharmacy and Therapeutics. 39 (2014) 4 - p. 404-410 , 2014

Link: https://doi.org/10.1111/..

9

Individualized pharmacokinetic risk assessment for developm..:

Gupta, N ; Al-Huniti, N.H ; Veng-Pedersen, P
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873702. , 2007

Link: http://www.ncbi.nlm.nih...

10

Predictive Performance of Physiologically Based Pharmacokin..:

Zhou, W ; Johnson, TN ; Xu, H...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036422/. , 2016

Link: http://www.ncbi.nlm.nih...

11

Model Evaluation of Continuous Data Pharmacometric Models :..:

Nguyen, T. H. T ; Mouksassi, M-S ; Holford, N...
CPT : Pharmacometrics and Systems Pharmacology (PSP), 2017, 6:2, s. 87-109. , 2017

Link: http://urn.kb.se/resolve..

12

List of Contributors:

, In: Transfusion Medicine and Hemostasis,

Acharya, Suchitra S. ; Aeschlimann, Judith ; Al-Huniti, Ahmad... - p. xvii-xxvi , 2019

Link: https://doi.org/10.1016/..

13

Predictive Performance of Physiologically Based Pharmacokin..:

Zhou, Wangda ; Johnson, Trevor N. ; Bui, Khanh H....
Clinical Pharmacology & Therapeutics. 104 (2017) 1 - p. 188-200 , 2017

Link: https://doi.org/10.1002/..

14

Simulation and Prediction of the Drug‐Drug Interaction Pote..:

Zhou, D ; Bui, K ; Sostek, M.
CPT: Pharmacometrics & Systems Pharmacology. 5 (2016) 5 - p. 250-257 , 2016

Link: https://doi.org/10.1002/..

15

Population Exposure‐Response Modeling of Naloxegol in Patie..:

Al‐Huniti, N ; Nielsen, JC ; Hutmacher, MM...
CPT: Pharmacometrics & Systems Pharmacology. 5 (2016) 7 - p. 359-366 , 2016

Link: https://doi.org/10.1002/..